Provider review
LifeMD tirzepatide review
LifeMD tirzepatide: dated cost records, plan details and questions to ask before enrolling. Public-source editorial, without a test purchase or clinical rating.
Updated 2026-09-18 · Public-source editorial · See dated evidence below
LifeMD is a physician-led service built around getting your medication covered by insurance, and it should be judged on that rather than on its monthly fee.
The GLP-1 programme is $75 for the first month and $149 a month thereafter, with an annual plan bringing it as low as $75 a month. That fee buys clinical care and administrative work — not medication. If your insurer declines, you pay the fee and the full medication cost separately.
Recorded costs and what to confirm
| Comparison step | Tirzepatide at LifeMD |
|---|---|
| Earlier figures | Dated cost record |
| Treatment | Name the product, route, prescribed amount and supply period |
| First payment | Itemize medicine, care, tests, supplies and delivery |
| Renewal | Give the next charge, its date and the supply it covers |
| Change or exit | Explain remaining charges and any refund before payment |
Programme fee only. Branded medication cost sits on top unless insurance covers it.
For a cash payer with no coverage prospect, this is a difficult sell. You are paying $149 a month for care and then buying medication at market price. For an insured patient, it can be the cheapest arrangement on this page.
How LifeMD works
Physician-led telehealth group with a weight-management programme built around insurance coordination and branded prescriptions.
The physician-led model is genuine, and the insurance coordination is the core service rather than a marketing line. For someone with a plan that might cover a GLP-1, that work is worth real money: the difference between a covered and uncovered prescription can be a thousand dollars a month.
The earlier source record
- GLP-1 injection programme listed at $75 first month, then $149/month.
- Annual plan advertised as low as $75/month.
- Programme fee does not include medication when medication is branded and billed to insurance.
- Markets insurance coordination that can reduce semaglutide cost to roughly $25/month where coverage applies.
The underlying record is dated 2026-09-18. Its amounts, plan details and service descriptions are historical. Confirm the exact product, billing interval, included services and renewal terms before using a figure as a budget.
Where it is strong
- Genuine clinician oversight with a physician-led model.
- Insurance work is a core part of the service, not an afterthought.
- Annual plan meaningfully reduces the programme fee.
Where it falls short
- The programme fee buys care, not medication.
- Cash-pay outcomes are far less attractive than insured ones.
The thing most people miss
If your insurer declines, the $149/month programme fee still applies and the medication is extra.
How it scored
The historical rubric gives LifeMD 3.5 out of 5. Display position 14 of 23 also reflects commercial placements; it is not a clinical quality rank. These scores have not been independently revalidated. See how we rate.
| What we weigh | Weight | Score |
|---|---|---|
| True monthly cost | 30% | 3 / 5 |
| Price honesty | 20% | 3.3 / 5 |
| Clinical support | 20% | 4 / 5 |
| Pharmacy sourcing | 15% | 4.2 / 5 |
| Cancelling | 15% | 3.4 / 5 |
Who it suits
Aimed squarely at insured patients. If you have already been denied, or you have no coverage at all, a flat-rate compounded programme will serve you better.
Our verdict
Strong clinical governance and real insurance advocacy, wrapped around a fee that only pays for itself if coverage comes through. Check your formulary before you sign anything.
How it compares on tirzepatide
| # | Provider | Cost record | Compare a new quote | Historical score |
|---|---|---|---|---|
| 1 | Coreage Rx Featured | Dated cost record | Product, supply, fees and renewal | 4.5 |
| 2 | SuperHealthy Rx | Dated cost record | Product, supply, fees and renewal | Not scored |
| 3 | Likeness Rx | Dated cost record | Product, supply, fees and renewal | Not scored |
| 4 | Trimi | Dated cost record | Product, supply, fees and renewal | 4.6 |
| 5 | PlexusDx | Dated cost record | Product, supply, fees and renewal | 4.4 |
| 6 | Ozari Health | Dated cost record | Product, supply, fees and renewal | 4.4 |
| 7 | Fifty 410 | Dated cost record | Product, supply, fees and renewal | 4.2 |
| 8 | Ivím Health | Dated cost record | Product, supply, fees and renewal | 4 |
| 9 | Mochi Health | Dated cost record | Product, supply, fees and renewal | 3.6 |
| 10 | Coby Health | Dated cost record | Product, supply, fees and renewal | 3.6 |
| 11 | Hims & Hers | Dated cost record | Product, supply, fees and renewal | 3.5 |
| 12 | Ro | Dated cost record | Product, supply, fees and renewal | 3.5 |
The full reasoning behind this order is in our best tirzepatide providers guide.
Read next
- Coreage Rx tirzepatide review
Coreage Rx tirzepatide: dated cost records, plan details and questions to ask before enrolling. Public-source editorial, without a test purchase or clinical rating.
- Likeness Rx semaglutide review
Likeness Rx semaglutide: dated cost records, plan details and questions to ask before enrolling. Public-source editorial, without a test purchase or clinical rating.
- Trimi tirzepatide review
Trimi tirzepatide: dated cost records, plan details and questions to ask before enrolling. Public-source editorial, without a test purchase or clinical rating.
- The best tirzepatide providers in 2026
23 historical provider records, with cost-component questions, clinical evidence limits and commercial placements explained.
- LifeMD semaglutide review
LifeMD semaglutide: dated cost records, plan details and questions to ask before enrolling. Public-source editorial, without a test purchase or clinical rating.
- How to Compare GLP-1 Costs: Fees, Refills and Renewal
Separate medication, care fees, supply duration, prepayment and renewal when comparing a GLP-1 quote.
Coreage Rx pays us a commission on sign-ups through our links. Commercial placements affect display order; the tables are not clinical recommendations. How we rate · Disclosure
